Anika Therapeutics Inc (ANIK)

Cash & Equivalents

$38.41M

Quarterly · Period ending: · USD

ANIK logo

ANIK Cash & Equivalents

Latest reported$57.48M
ANIK FY Cash & Equivalents ($5.10M → $57.48M)
High-resolution chart · PNG

ANIK cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
57,481,000
55,629,000
68,740,000
86,327,000
94,386,000
95,817,000
157,463,000
89,042,000
133,256,000
104,261,000
110,707,000
100,155,864
63,333,160
44,067,477
35,777,222
28,201,932
24,426,990
43,193,655
35,903,569
47,167,432
44,747,000
39,339,000
14,592,000
11,001,596
9,064,977
8,265,936
6,400,000
10,700,000
22,700,000
2,700,000
2,800,000
2,600,000
5,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.